Activated Clotting Time During Unfractionated Heparin-Supported Coronary Intervention Is Access Site the New Piece of the Puzzle?

被引：1
作者：
Valgimigli, Marco [1 ]
Gargiulo, Giuseppe [1 ]
机构：
[1] Univ Bern, Univ Hosp Bern, Dept Cardiol, Bern, Switzerland
来源：
JACC-CARDIOVASCULAR INTERVENTIONS | 2018年 / 11卷 / 11期
关键词：
activated clotted time (ACT); clinical outcomes; heparin; percutaneous coronary intervention (PCI); radial access; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; ANTICOAGULATION; IMPACT; THERAPY; COMPLICATIONS; TRIALS;
D O I：
10.1016/j.jcin.2018.02.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1046 / 1049
页数：4
相关论文
共 18 条
  • [11] Association of an activated clotting time ≤250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (A TACTICS-TIMI 18 substudy)
    Pinto, DS
    Lorenz, DP
    Murphy, SA
    Marble, SJ
    DiBattiste, PM
    Demopoulos, LA
    Cannon, CP
    Gibson, CM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (08) : 976 - 978
  • [12] Relation of Activated Clotting Times During Percutaneous Coronary Intervention to Outcomes
    Rajpurohit, Naveen
    Gulati, Rajiv
    Lennon, Ryan J.
    Singh, Mandeep
    Rihal, Charanjit S.
    Santrach, Paula J.
    Donato, Leslie J.
    Karon, Brad S.
    Del-Carpio, Freddy
    Tak, Tahir
    Motiei, Arashk
    Lopes, Renato D.
    Gharacholou, Shahyar Michael
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (05) : 703 - 708
  • [13] Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction
    Rozenman, Yoseph
    Mehran, Roxana
    Witzenbichler, Bernhard
    Dangas, George
    Desaga, Martin
    Kochman, Janusz
    Nilsen, Dennis W.
    Finkelstein, Ariel
    Mosseri, Morris
    Stone, Gregg W.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (01) : E9 - E15
  • [14] Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention - Observations from the ESPRIT trial
    Tolleson, TR
    O'Shea, JC
    Bittl, JA
    Hillegass, WB
    Williams, KA
    Levine, G
    Harrington, RA
    Tcheng, JE
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (03) : 386 - 393
  • [15] Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
    Valgimigli, M.
    Frigoli, E.
    Leonardi, S.
    Rothenbuehler, M.
    Gagnor, A.
    Calabro, P.
    Garducci, S.
    Rubartelli, P.
    Briguori, C.
    Ando, G.
    Repetto, A.
    Limbruno, U.
    Garbo, R.
    Sganzerla, P.
    Russo, F.
    Lupi, A.
    Cortese, B.
    Ausiello, A.
    Ierna, S.
    Esposito, G.
    Presbitero, P.
    Santarelli, A.
    Sardella, G.
    Varbella, F.
    Tresoldi, S.
    de Cesare, N.
    Rigattieri, S.
    Zingarelli, A.
    Tosi, P.
    van 't Hof, A.
    Boccuzzi, G.
    Omerovic, E.
    Sabate, M.
    Heg, D.
    Jueni, P.
    Vranckx, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (11) : 997 - 1009
  • [16] Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
    Valgimigli, Marco
    Gagnor, Andrea
    Calabro, Paolo
    Frigoli, Enrico
    Leonardi, Sergio
    Zaro, Tiziana
    Rubartelli, Paolo
    Briguori, Carlo
    Ando, Giuseppe
    Repetto, Alessandra
    Limbruno, Ugo
    Cortese, Bernardo
    Sganzerla, Paolo
    Lupi, Alessandro
    Galli, Mario
    Colangelo, Salvatore
    Ierna, Salvatore
    Ausiello, Arturo
    Presbitero, Patrizia
    Sardella, Gennaro
    Varbella, Ferdinando
    Esposito, Giovanni
    Santarelli, Andrea
    Tresoldi, Simone
    Nazzaro, Marco
    Zingarelli, Antonio
    de Cesare, Nicoletta
    Rigattieri, Stefano
    Tosi, Paolo
    Palmieri, Cataldo
    Brugaletta, Salvatore
    Rao, Sunil V.
    Heg, Dik
    Rothenbuehler, Martina
    Vranckx, Pascal
    Jueni, Peter
    [J]. LANCET, 2015, 385 (9986) : 2465 - 2476
  • [17] Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention
    Verheugt, Freek W. A.
    Steinhubl, Steven R.
    Hamon, Martial
    Darius, Harald
    Steg, Philippe Gabriel
    Valgimigli, Marco
    Marso, Steven P.
    Rao, Sunil V.
    Gershlick, Anthony H.
    Lincoff, A. Michael
    Mehran, Roxana
    Stone, Gregg W.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (02) : 191 - 197
  • [18] Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction
    Vranckx, Pascal
    Campo, Gianluca
    Anselmi, Maurizio
    Bolognese, Leonardo
    Colangelo, Salvatore
    Biondi-Zoccai, Giuseppe
    Moreno, Raul
    Piva, Tommaso
    Favero, Luca
    Prati, Francesco
    Nazzaro, Marco
    Fernandez, Jose F. Diaz
    Ferrari, Roberto
    Valgimigli, Marco
    [J]. EUROINTERVENTION, 2012, 8 (01) : 71 - 78
12